2236 related articles for article (PubMed ID: 34610047)
1. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology.
Arikan H; Ozturk S; Tokgoz B; Dursun B; Seyahi N; Trabulus S; Islam M; Ayar Y; Gorgulu N; Karadag S; Gok M; Akcali E; Bora F; Aydın Z; Altun E; Ahbap E; Polat M; Soypacacı Z; Oguz EG; Koyuncu S; Colak H; Sahin İ; Dolarslan ME; Helvacı O; Kurultak I; Eren Z; Dheir H; Ogutmen MB; Taymez DG; Genek DG; Ozkurt S; Bakır EA; Yuksel E; Sahutoglu T; Oto OA; Boz G; Sengul E; Kara E; Tuglular S
PLoS One; 2021; 16(8):e0256023. PubMed ID: 34375366
[TBL] [Abstract][Full Text] [Related]
4. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
[TBL] [Abstract][Full Text] [Related]
6. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study.
Abdel-Qadir H; Austin PC; Sivaswamy A; Chu A; Wijeysundera HC; Lee DS
BMC Public Health; 2023 Mar; 23(1):482. PubMed ID: 36915068
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
[TBL] [Abstract][Full Text] [Related]
9. Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement.
Jämsä P; Jämsen E; Huhtala H; Eskelinen A; Oksala N
Clin Orthop Relat Res; 2018 Jun; 476(6):1284-1292. PubMed ID: 29601379
[TBL] [Abstract][Full Text] [Related]
10. Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study.
Gimeno-Miguel A; Bliek-Bueno K; Poblador-Plou B; Carmona-Pírez J; Poncel-Falcó A; González-Rubio F; Ioakeim-Skoufa I; Pico-Soler V; Aza-Pascual-Salcedo M; Prados-Torres A; Gimeno-Feliu LA;
PLoS One; 2021; 16(11):e0259822. PubMed ID: 34767594
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
12. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
[TBL] [Abstract][Full Text] [Related]
13. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
14. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain.
Vila-Córcoles A; Ochoa-Gondar O; Satué-Gracia EM; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Basora-Gallisà J
BMJ Open; 2020 Dec; 10(12):e041577. PubMed ID: 33303459
[TBL] [Abstract][Full Text] [Related]
15. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.
Mah J; Lieu A; Palayew M; Alipour P; Kong LY; Song S; Palayew A; Tutt-Guérette MA; Yang SS; Wilchesky M; Lipes J; Azoulay L; Greenaway C
CMAJ Open; 2021; 9(3):E718-E727. PubMed ID: 34257090
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG;
JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group
Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698
[TBL] [Abstract][Full Text] [Related]
20. History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case-control study.
Gu T; Chu Q; Yu Z; Fa B; Li A; Xu L; Wu R; He Y
BMJ Open; 2020 Sep; 10(9):e038976. PubMed ID: 32948572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
